Celularity Inc
Develops off-the-shelf cell therapies from placentas for cancer and aging-related diseases.
CELU | NDAQ
Overview
Corporate Details
- ISIN(s):
- US1511901050 (+2 more)
- LEI:
- Country:
- United States of America
- Address:
- 170 PARK AVE, 7932 FLORHAM PARK
- Website:
- https://celularity.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Celularity Inc. is a clinical-stage biotechnology company specializing in regenerative and cellular medicine. The company develops and commercializes allogeneic, off-the-shelf cell therapies and advanced biomaterial products derived from the postpartum human placenta. Its therapeutic programs target aging-related conditions, including cancer, degenerative diseases, and immune disorders. Celularity's platforms utilize placental-derived cells such as mesenchymal-like adherent stromal cells (MLASCs), T-cells engineered with CAR (CAR T-cells), and natural killer (NK) cells. By harnessing the unique biology of the placenta, the company aims to provide effective, accessible, and affordable therapies for significant unmet medical needs.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Celularity Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Celularity Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Celularity Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
